5-Fluorouracil-loaded poly(∊-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

Ortiz, Raúl; Prados, José; Melguizo, Consolación; Arias, José L.; Ruiz, M. Adolfina; Álvarez, Pablo J.; Caba, Octavio; Luque, Raquel; Segura, Ana; Aránega, Antonia
January 2012
International Journal of Nanomedicine;2012, Vol. 7, p95
Academic Journal
No abstract available.


Related Articles

  • Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae. Kęsik-Szeloch, Agata; Drulis-Kawa, Zuzanna; Weber-Dąbrowska, Beata; Kassner, Jerzy; Majkowska-Skrobek, Grazyna; Augustyniak, Daria; Łusiak-Szelachowska, Marzanna; Żaczek, Maciej; Górski, Andrzej; Kropinski, Andrew M. // Virology Journal;2013, Vol. 10 Issue 1, p1 

    Background: Members of the genus Klebsiella are among the leading microbial pathogens associated with nosocomial infection. The increased incidence of antimicrobial resistance in these species has propelled the need for alternate/combination therapeutic regimens to aid clinical treatment....

  • The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131. Yun Choi; Ho Won Lee; Jaetae Lee; Yong Hyun Jeon // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: It is important to simultaneously induce strong cell death and antitumor immunity in cancer patients for successful cancer treatment. Here, we investigated the cytotoxic and phenotypic modulation effects of the combination of ANT2 shRNA and human sodium iodide symporter (hNIS)...

  • Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus. Zhou, W; Zhu, H; Chen, W; Hu, X; Pang, X; Zhang, J; Huang, X; Fang, B; He, C // Cancer Gene Therapy;May2011, Vol. 18 Issue 5, p336 

    Oncolytic virus-armed gene therapy may offer new treatment options and improve the prognosis for patients with colon cancer. In this study, we sought to further confirm the antitumor activity of oncolytic virus-armed tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy in...

  • Phages Affect Gene Expression and Fitness in E. coli. Chen, Y.; Golding, I.; Sawai, S.; Guo, L.; Cox, E. C. // PLoS Biology;Jul2005, Vol. 3 Issue 7, p1153 

    The article presents information related to the study of bacteriophages that affect gene expression and fitness in E. coli. Two types of bacteriophages threaten bacteria, lytic phages and lysogenic phages. Working with λ phages, the authors studied how phage infection affects the regulation...

  • Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdΔ24. Oosterhoff, D.; Pinedo, H. M.; Witlox, M. A.; Carette, J. E.; Gerritsen, W. R.; van Beusechem, V. W. // Gene Therapy;Jun2005, Vol. 12 Issue 12, p1011 

    Conditionally replicating adenoviruses (CRAds) selectively replicate in and thereby kill cancer cells. The CRAd AdΔ24 with pRb-binding-deficient E1A kills cancer cells efficiently. Arming CRAds with genes encoding prodrug-converting enzymes could allow for enhanced anticancer efficacy by the...

  • A one-two punch. Gutfeld, Greg; Meyers, Melissa; Sangiorgio, Maureen // Prevention;Nov90, Vol. 42 Issue 11, p20 

    Reports on a new combination drug therapy which repels colon cancer. Levamisole and fluorouracil.

  • Nanoparticle-based Cerebral Drug-Delivery Systems and Antiangiogenic Approach in Gliomas Treatment. Raudino, Giuseppe; Caffo, Mariella; Caruso, Gerardo; Alafaci, Concetta; Tomasello, Francesco // Recent Patents on Nanotechnology;Nov2011, Vol. 5 Issue 3, p239 

    The efficacy of current anti-cancer multimodal therapeutic strategies in gliomas is limited by the lack of specific therapies against malignant cells and the prognosis in patients affected by cerebral gliomas remains very unfavorable. Glial tumors seem to be able to create a favorable...

  • Improvement of different vaccine delivery systems for cancer therapy. Bolhassani, Azam; Safaiyan, Shima; Rafati, Sima // Molecular Cancer;2011, Vol. 10 Issue 1, p1 

    Cancer vaccines are the promising tools in the hands of the clinical oncologist. Many tumor-associated antigens are excellent targets for immune therapy and vaccine design. Optimally designed cancer vaccines should combine the best tumor antigens with the most effective immunotherapy agents...

  • A Novel Double-Enhanced Suicide Gene Therapy in a Colon Cancer Cell Line Mediated by Gef and Apoptin. Boulaiz, Houria; Aránega, Antonia; Blanca, Cáceres; Pablo, Alvarez; Fernando, Rodríguez-Serrano; Esmeralda, Carrillo; Consolación, Melguizo; Jose, Prados // BioDrugs;Feb2014, Vol. 28 Issue 1, p63 

    Background: Double-suicide gene therapy is a promising strategy for the treatment of advanced cancer. It has become an important research line in the development of gene therapy to overcome the drawbacks of single-gene therapy. Objective: The aim of this study was to investigate the usefulness...

  • Genetic characterization of Pseudomonas aeruginosa bacteriophage KPP10. Uchiyama, Jumpei; Rashel, Mohammad; Takemura, Iyo; Kato, Shin-ichiro; Ujihara, Takako; Muraoka, Asako; Matsuzaki, Shigenobu; Daibata, Masanori // Archives of Virology;Apr2012, Vol. 157 Issue 4, p733 

    Bacteriophage (phage) KPP10 has been used in experimental phage therapies directed against P. aeruginosa infections. To examine the eligibility of phage KPP10 as a therapeutic phage, its genome was analyzed. The genomic DNA was shown to be 88,322 bp long, with 158 open reading frames (ORFs), and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics